Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
The current price of Eli Lilly And Co in the market is ₺51.829,24, with a 24-hour trading volume of ₺180,71B. The asset's market cap is ₺46,21T, after moving 0.55% in the last day.
Tokenized Eli Lilly And Co is trading at ₺52.022,76, with a tokenized market cap of ₺1,96B and a 24-hour trading volume of ₺110,11M. The tokenized asset has moved -5.14% in the past 24 hours.